Nanoparticle-Based Drug Delivery In Asthma Therapy

Abstract

According to the World Health Organization, the combined economical effect of AIDS and tuberculosis exceeds
that of asthma (WHO). Due to the high rates of disability and mortality, it has developed into a significant public
health problem. Asthma is a complicated disorder influenced by both inherited and environmental factors.
Nanotechnology advancements have reintroduced hope for the early detection, treatment, and prevention of
asthma, owing to the disease's intricate pathogenesis. Nanotechnology offers the ability to deliver pharmaceuticals
or genes exactly where they are required, while also minimising adverse effects and improving drug absorption. In
recent years, a major research emphasis has been on the development of innovative nanodrugs and the
modification of current treatments. Clinical experiments have shown that nanocarriers are both safe and effective.
However, various hurdles must be cleared before nanotherapy may be employed in clinical practise. We'll look at
some of the most current research discoveries in the subject of nanotechnology and asthma therapy in this article.